Evidence map›Paper›PMID 40197508›Full record

Observational studyCritical care (London, England)2025

Prognosis of liver abscess in the intensive care unit (POLAIR), a multicentre observational study.

Marie Le Goff, Frédéric Martino, Geoffrey Rossi, Aurélia Toussaint, Elsa Moncomble, Danielle Reuter, Charlotte Garret, Maxence Decavèle, Megan Fraissé, Antoine Herault and 16 more

Abstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Critical care (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Aeromonas caviae: A rare case of hepatic abscess.GMS hygiene and infection control · 2026
    Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Marie Le GoffAP-HP, Hôpital Saint-Louis, Medical ICU, Paris, France. marie.legoff@aphp.fr.
Frédéric MartinoIntensive Care Unit, CHU de Guadeloupe, Chemin Chauvel, Les Abymes, Guadeloupe.
Geoffrey RossiDepartment of Internal Medicine, Beaujon Hospital, GHU AP-HP Nord, Université Paris Cité, Clichy, France.
Aurélia ToussaintIntensive Care Unit, CHD La Roche sur Yon, La Roche-sur-Yon, France.
Elsa MoncombleAP-HP (Assistance Publique-Hôpitaux de Paris), Hôpitaux Universitaires Henri Mondor, DMU Médecine, Service de Médecine Intensive Réanimation, CHU Henri Mondor, 51, Av. de Lattre de Tassigny, 94010, Créteil CEDEX, France.
Danielle ReuterMedical-Surgical Intensive Care Unit, Sud Francilien Hospital, Corbeil, France.
Charlotte GarretMedical Intensive Care, Hôtel Dieu University Hospital, Nantes, France.
Maxence DecavèleService de Médecine Intensive et Réanimation (Département R3S), Groupe Hospitalier Universitaire APHP-Sorbonne Université, Site Pitié-Salpêtrière, 75013, Paris, France.
Megan FraisséMedical Intensive Care Unit, Ambroise Paré Hospital, APHP, Boulogne, France.
Antoine HeraultHôpital Charles Nicolle, Medical ICU, Rouen, France.
Laurent ArgaudGroupement Hospitalier Edouard Herriot, Service de Réanimation Médicale, Lyon, France.
Pierre GarçonMedical and Surgical Intensive Care Unit, Grand Hôpital de L'Est Francilien Site Marne-la-Vallée, Jossigny, France.
Clément SaccheriService de Réanimation Médicale, CHU de Nice, Nice, France.
Juliette MeunierService de Réanimation Médicale, CH Le Mans, Le Mans, France.
Guillaume VoriotService de Médecine Intensive Réanimation, Hôpital Tenon, Hôpitaux de Paris, Paris, France.
Cyril CadozIntensive Care Unit, Metz-Thionville Regional Hospital, Mercy Hospital, Metz, France.
Élise YvinDépartement de Médecine Intensive-Réanimation, CHU Angers, Angers, France.
Virginie LaurentPolyvalent Intensive Care Unit, André Mignot Hospital, 78150, Le Chesnay, France.
Laure CalvetCHU de Clermont-Ferrand, Service de Médecine Intensive et Réanimation, Clermont-Ferrand, France.
Etienne de MontmollinMedical Intensive Care Unit, APHP, Hôpital Bichat-Claude Bernard, Paris, France.
Julien SchmidtService de Réanimation Médico-Chirurgicale, Hôpital Avicenne, Assistance Publique-Hôpitaux de Paris, Paris, France.
Nahema IssaMedical Intensive Care and Infectious Diseases Unit, Hôpital Saint André, Bordeaux, France.
Maxime LeclercService de Réanimation et Soins Intensifs Polyvalents, CH Mémorial Saint-Lô, Saint-Lô, France.
Vincent DasMedical-Surgical Intensive Care Unit, Centre Hospitalier Intercommunal André Grégoire, Montreuil, France.
Virginie LemialeAP-HP, Hôpital Saint-Louis, Medical ICU, Paris, France.
Éric MariotteAP-HP, Hôpital Saint-Louis, Medical ICU, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLiver abscess (LA) is a rare but potentially serious condition with a high mortality rate. Current epidemiological data of LA patients requiring intensive care unit (ICU) admission are limited.

methodsThis multicentre retrospective study included adults admitted to 24 ICUs in France between January 2010 and December 2020. Risk factors for mortality were identified by multivariate analysis. A propensity score was used to adjust for confounders related to the presence of portal vein thrombosis.

results335 patients were enrolled. The median age was 66 years [53-73] and 68% were male. Commons comorbidities included diabetes (29.9%) and cancer or haematological disease. Septic shock was the main reason for admission (58%). The median SAPS2 score at ICU admission was 42 [31-53] and the SOFA score was 6 [3-9]. The putative origin of LA was biliary (31%), while 40% were cryptogenic. Most patients (60%) had a solitary LA, involving the right lobe (38.8%), with a median diameter of 67 mm [47-91]. Associated portal vein thrombosis (PVT) was present in 13.4% of cases. Microbiological documentation was obtained in 82% of patients, showing gram-negative bacilli (59.7%), mainly Escherichia coli (19.6%) and Klebsiella spp. (19.1%), and gram-positive cocci (29.6%), mainly Streptococcus spp. (17.1%). Drainage was performed in 62% of cases, 40% within 48 h. The median duration of antibiotic therapy was 35 days [21-42]. During hospitalisation, 62% of patients required vasopressors and 29% required mechanical ventilation. In-ICU mortality was 11.6%. Multivariate analysis showed that organ dysfunction illustrated by SOFA score (HR 3.45 [1.95-6.09], p < 0.001) and PVT (HR 3.14 [1.54-6.39], p = 0.001) were significant risk factors for mortality. Drainage was not associated with improved short-term survival (HR 1.22 [0.65-2.72], p = 0.52). In the population matched for PVT confounders, a higher sofa score was the only factor associated with mortality (HR 3.11 [1.76-5.49] IC95%, p = 0.001).

conclusionsThis multicentre study illustrates the severity of LA in French intensive care units and identifies organ dysfunction (SOFA score) and portal vein thrombosis as major risk factors for mortality. Prospective studies are needed to improve management strategies, as the survival benefit of drainage is unclear.

Indexed as

Liver AbscessAgedFemaleFranceHumansIntensive Care UnitsMaleMiddle AgedPrognosisPropensity ScoreRetrospective StudiesRisk FactorsIntensive careLiver abscessMicrobiologyMortalityPortal vein thrombosisPrognosis

Identifiers

PMID40197508
PMCPMC11974115

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.